Although we have identified that Klotho expression confers hepatoma cells with resistance to anoikis through VEGFR2/PAK1 activation, the underlying molecular mechanism for Klotho-mediated VEGFR2/PAK1 activation remains still obscure and needs further exploration. Here, KDR is linked to hepatocellular carcinoma.